others simply dont eat because theyre not hungry, so malnutrition can be an issue, says Leigh ODonnell, head of shopper and category insights at Kantar Retail IQ, which conducts ongoing shopper research on GLP-1 users
Hansoh Bio out-licenses dual incretin receptor agonist to Regeneron On June 2, Hansoh Pharma announced an exclusive licensing agreement with Regeneron for HS-20094, a GLP-1R/GIPR dual agonist
This sleep peptide is designed for individuals seeking sleep quality improvement, deep sleep enhancement, recovery optimization, and comprehensive sleep wellness through evidence-based sleep architecture support
The observed effect was attributed to DSePA-mediated suppression of DNA damage response pathways and, in turn, the inhibition of DNA repair in the irradiated lung cancer cells
Presented for research literature review only Baek MC et al
doi: 10.1111/j.1398-9995.2005.00939.x PubMed Abstract | CrossRef Full Text | Google Scholar Alloway, B